Safety of coronary Sirolimus-Eluting Stents in daily clinical practice - One-year follow-up of the e-cypher registry

Article

关键词: ACUTE MYOCARDIAL-INFARCTION;    RANDOMIZED CONTROLLED-TRIAL;    ANTIPLATELET THERAPY;    MULTIVESSEL DISEASE;    POOLED ANALYSIS;    THROMBOSIS;    IMPLANTATION;    LESIONS;    ARTERY;    RESTENOSIS;   

DOI  :  10.1161/CIRCULATIONAHA.104.532242

来源: SCIE

【 摘 要 】

Background - The expanding indications for sirolimus-eluting stents (SES) include increasingly complex coronary lesions and populations with clinical profiles markedly different from those of early pivotal controlled studies. The e-Cypher registry monitored the safety and efficacy of SES currently implanted worldwide in daily practice. Methods and Results - Between April 2002 and September 2005, data were collected on 15 157 patients who underwent implantation of >= 1 SES at 279 medical centers from 41 countries. An independent endpoint review committee adjudicated all reported major adverse cardiovascular events, stent thromboses, and target-vessel revascularizations. Data were managed and analyzed by independent organizations. Predictors of adverse clinical events were identified by regression analysis. The mean age of the sample was 61.7 +/- 11.4 years; 77.7% were men, and 28.6% were diabetics. A total of 18 295 lesions were treated (20 503 SES) during the index procedure. The cumulative rates of major adverse cardiovascular events were 1.36% at 30 days, 3.38% at 6 months, and 5.80% at 1 year. The rates of acute, subacute, and late stent thrombosis were 0.13%, 0.56%, and 0.19% of patients, respectively, representing a 12-month actuarial incidence of 0.87%. Insulin-dependent diabetes, acute coronary syndrome at presentation, and advanced age were clinical predictors, whereas TIMI flow grade < 3 after the index procedure, treatment of multiple lesions, a prominently calcified or totally occluded target lesion, and multivessel disease were the angiographic or procedural predictors of stent thrombosis at 12 months. Conclusions - This analysis of 1-year data collected by the e-Cypher registry suggests a high degree of safety of SES, with a rate of stent thrombosis similar to that observed in randomized trials.

【 授权许可】

Free